Please login to the form below

Not currently logged in
Email:
Password:

Redx poaches AstraZeneca senior executive

Lisa Anson joins the UK biotech as its CEO

Lisa AnsonDrug discovery and development group Redx Pharma has appointed its new chief executive officer in the form of Lisa Anson.

Anson, who was previously AstraZeneca’s UK president since 2012, also joins Redx’s board of directors, taking up both roles on 1 June.

With a 20-year career with AstraZeneca, Anson has held a variety of senior management roles at the pharmaceutical company, situated in both the US and UK, including global vice president oncology, and vice president of emerging brands, working closely with the research and development teams.

Ian Ross, executive chairman of Redx, said: “Lisa has been tasked by the board to lead the re-launch of the company and to take the steps necessary to build a substantial biotech company built upon an innovative science base, selectively acquiring additional assets.

“Lisa is a consummate business professional, who brings a wealth of relevant experience from the international pharmaceutical and biotech sector and I am confident that she is the right person to grow this company into a very excising and meaningful entity that has the potential to create both important new medicines for patients and generate significant value for shareholders."

27th April 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...

Infographics